<![CDATA[Treating excessive sweating or focal hyperhidrosis - Sweating Matters Blog]]>Mon, 26 Feb 2024 12:53:39 -0800Weebly<![CDATA[The Three Causes of Hyperhidrosis]]>Thu, 29 Nov 2018 14:46:54 GMThttp://drypharmacist.com/sweating-matters-blog/november-29th-2018
As per most things related to the human body, things are always more complicated than they appear. And so goes the cause, or more accurately causes of hyperhidrosis. A recent review study* points to multiple causes behind the excessive sweating condition. When 'googling' the cause of hyperhidrosis, an 'overactive' nervous stimulation of sweat glands is often cited as the cause of the condition.  While this is true, two other causes need to be included as sources of excessive sweating.
More recently, researchers have identified a specific gene that is 'overexpressed' resulting in a greater production of aquaporin proteins. These proteins sit within sweat glands and are responsible for pumping water into sweat gland ducts. Another often forgotten cause is the greater number of acetylcholine receptors. Acetylcholine is a well known neurotransmitter that facilitates the travel of signals between nerve cells. Nerve signals are transmitted when acetylcholine binds to nerve cell surface receptors. A greater number of receptors on a nerve cell surface renders these cells more sensitive. Essentially, a greater number of acetylcholine receptors translates into a stronger nerve signal which in turn instructs glands to sweat more 'aggressively'.
Identifying the multiple causes of focal hyperhidrosis is particularly important to help researchers focus of multiple avenues as possible targets of therapy.
*Clin Auton Res. 2017 Dec;27(6):379-383
]]>
<![CDATA[Passing on the Gene]]>Sat, 20 Oct 2018 15:25:06 GMThttp://drypharmacist.com/sweating-matters-blog/passing-on-the-gene
For some time now, we know physical traits such as eye color are linked to parental carrier genes. One of my book reads this Summer was based on whether more intangible characteristics such as intelligence, instinct, or behaviour might have a genetic link or be associated with a particular gene. While the book shed light on this intriguing topic, much research is needed to conclusively determine whether a link exists. Things are a little clearer when it comes to focal or primary hyperhidrosis. Research indicates that 50% of individuals that have hyperhidrosis also have a family history of the condition. 
​​Luckily, the hyperhidrosis gene is not dominant which means that not all children will inherit the condition. The gene penetration rate is 25% which means 1 in 4 children will inherit the condition. While I am not an expert in statistics, this risk ratio does not necessarily guarentee that if you have 4 children, one will inherit hyperhidrosis. Conversely, there is a risk that 2 of 4 children could develop hyperhidrosis. But the likelihood of having two children inheriting the condition is only 1 in 16. And the likelihood of having 3 children with the condition becomes almost improbable, that is, 1 in 64. To a degree, this explains why only a small percentage of the population have hyperhidrosis. For more information go to our Hyperhidrosis Heredity Survey page.
]]>
<![CDATA[Botox and botulism]]>Tue, 19 Jun 2018 21:43:57 GMThttp://drypharmacist.com/sweating-matters-blog/botox-and-botulism
While the intent is not to be alarmist, many of us may not be aware that there exists a small risk that a Botox injection is capable of spreading to neighbouring nerve tissue and putting the recipient at risk of botulism. An article in an August 2016 issue of the Guardian* reports on a study from the University of Wisconsin which demonstrates that Botox may travel between nerve cells and therefore elevate the risk of experiencing symptoms of botulism. 
While the study** used an animal model, it does raise the issue of the ability of Botox spreading in human nerve tissue. The notion that Botox could spread has always been discarded, the prevailing thought being that Botox remains in the region it is injected.
Most people would be surprised that the US Food and Drug Administration (FDA) added a safety warning in 2009 that mentions the toxin “may spread from the area of injection to produce symptoms of botulism”. These include muscle weakness and the possibility breathing difficulties that can occur hours or weeks after an injection.
More recently, an outbreak (8 cases) of botulism was reported from Egypt after injections of the neurotoxin in a variety of patients (including 1 in hyperhidrosis)***. The injectable was sold under the name Neuroxin. Click the following link for more on the symptoms of botulism.
*https://www.theguardian.com/lifeandstyle/2016/aug/27/botox-safe-new-research-testing-toxins-fda
**Clin Neuropharmacol. 2012 Sep-Oct;35(5):254-7. ***Basic Clin Pharmacol Toxicol. 2018 May 22. doi: 10.1111/bcpt.13048. [Epub ahead of print]
]]>
<![CDATA[Abilify....friend or foe]]>Tue, 01 May 2018 14:56:42 GMThttp://drypharmacist.com/sweating-matters-blog/abilifyfriend-or-foe
Abilify, a relatively new drug is often used in combination with an anti-depressant to synergize the latter's effect. At times, the effect of an anti-depressant alone doesn't quite do the job. Adding an agent like Abilify increases the overall anti-depressant effect. Another added benefit of Abilify happens to be its ability to offset excessive sweating that is sometimes experienced with an anti-depressant*. Many other drugs have been found to induce excessive sweating, including opiate painkillers, anti-hypertensives, and  some antibiotics (see our page on drug-induced hyperhidrosis)
While Abilify might help to neutralize anti-depressant induced hyperhidrosis, clinical investigators from Turkey have recently reported that Abilify might cause excessive sweating**.  The authors report on two female case studies that developed hyperhidrosis while being treated with Abilify. The good news is the patients stopped experiencing hyperhidrosis after their Abilify was discontinued.

*J Clin Psychopharmacol. 2008 Dec;28(6):710-1  **Turk Psikiyatri Derg. 2017 Summer;28(2):132-134.
]]>
<![CDATA[Iontoporesis and Children]]>Sun, 03 Dec 2017 16:24:58 GMThttp://drypharmacist.com/sweating-matters-blog/iontoporesis-and-children
Treating children that suffer from hyperhidrosis can be particularly challenging. A new study* demonstrates that iontophoresis might be a good choice given that it is quite effective and safe. A little over 40 individuals aged 8 to 17 years were treated with iontophoresis. Patients underwent 7 sessions. Most frequent side effects include paresthesia (feeling of pins and needles) in 88%, pruritis or ichyness (26%), pain (26%), erythema or redness (14%), and dryness (12%). One patient experienced formation of vesicles and abrasions. 
A positive outcome was found in 84% of children. A measure of sweating severity, the HDSS score, was reduced from 3.5 to 2. In other words, pre-treatment sweating was rated as barely tolerable or intolerable. After treatment, sweating was rated as tolerable. If you are a parent, make sure you try topical gels and/or iontophoresis before you consider surgical options. Remember that a topical gel can be used together with iontophoresis to maximize topical treatment. 
* J Pediatr Surg 2017: 52(2): 309
]]>
<![CDATA[Hyperhidrosis and Kids - its impact on QoL]]>Mon, 16 Oct 2017 13:58:04 GMThttp://drypharmacist.com/sweating-matters-blog/hyperhidrosis-and-kids-its-impact-on-qol
Focal hyperhidrosis is often perceived as simply a condition of excessive sweating. For those that suffer and individuals close to them well know that hyperhidrosis has significant impact on quality of life (QoL). Children are no exception.
A recent Swedish study* of over 300 children (under 18 years) has quantified the impact hyperhidrosis has on these young lives. QoL effects were rated as no effect, small effect, moderate effect, very large effect or extremely large effect. On average, children rated the impact of hyperhidrosis on their QoL as having 'a very large effect'.
Most commonly reported comments/complaints from the children include negative self-esteem, inhibited physical and social contacts, problems with clothing, and practical impact on school work. Avoidance of social events, career opportunities, jobs or meeting a partner are also consequence-related symptoms mentioned by the children.
This study underscores the importance of identifying and treating focal hyperhidrosis in children. Over and above the excessive sweating, its long-term effects can have a serious impact on a child's future. 
Acta Derm Venereol. 2017 Aug 1. doi: 10.2340/00015555-2755. [Epub ahead of print]
]]>
<![CDATA[New Technique Helps Better Understand Sweat Gland]]>Fri, 18 Aug 2017 14:39:54 GMThttp://drypharmacist.com/sweating-matters-blog/new-technique-helps-better-understand-sweat-gland
Scientists are applying a cell culturing technique called 'hanging drop culture' to better understand sweat glands. Typical cell cultures are grown in dishes that allow them to multiply and thrive in a two dimensional format. The hanging drop technique allows a cell culture to organize itself in a 3-dimensional fashion. As such, this technique allows cell cultures to 
more realistically mimic the natural organization of cells within tissues. After all, sweat glands are 3-dimensional physiological units. 
Not only are the 3D cultures more lifelike, they also respond and function like real sweat glands. A numbers of tests have shown that 3D cultures behave more like real sweat glands. For example, adding acetylcholine (a neurotransmitter) to the 3-d cultures results in the influx of calcium within the cells. This process is normally observed within sweat glands. Cells cultures organized in typical 2D cultures do not respond to acetylcholine in this manner. Scientists are hoping the use of 3D sweat cell cultures will help determine which bioactive substances will best regulate the sweating process within these cells.
*A novel organotypic 3D sweat gland model with physiological functionality. PLoS One. 2017 Aug 10;12(8):e0182752
]]>
<![CDATA[Menopause and hyperhidrosis]]>Thu, 25 May 2017 21:04:39 GMThttp://drypharmacist.com/sweating-matters-blog/menopause-and-hyperhidrosis
While menopause marks the end of a woman's ability to conceive, it's symptoms usually undermine this significant physiological change. Better known for its annoying symptoms, these include hot flushes, sleep disturbances, mood swings and night sweats. While not very common, craniofacial hyperhidrosis is also a symptom associated with menopause. Unlike typical focal hyperhidrosis, 'menopausal hyperhidrosis' occurs later in life, is very difficult to treat, does not appear to be inherited and eventually subsides.
Based on cases* reported from the UK, 'menopausal hyperhidrosis' appears to be localized or limited to the facial and scalp regions. It also seems to be resistant to typical treatment. Patients failed to respond to oral or topical glycopyrrolate. Response was also poor with Botulinum toxin injections. The good news is that its duration does not seem permanent. The average duration in the cases reported was eight years. This type of sweating should not be confused with night sweats or hot flashes. 
*Australasia J Dermatol. 2012 May;53(2):158-9
]]>
<![CDATA[Size Matters...]]>Fri, 24 Mar 2017 21:09:41 GMThttp://drypharmacist.com/sweating-matters-blog/size-matters
When it comes to compensatory sweating, size matters. At least that's what a recent study* indicates. It is a well known fact that while surgery (thoracic sympathectomy) is an effective means of treating palmar hyperhidrosis, it can often lead to significant compensatory sweating. Investigators have recently shown that individuals with a BMI (body mass index, an indicator based on weight and height) of 25 or more are likely to develop more severe forms of post-surgical compensatory sweating compared to those with a BMI below 25. 

And the increase in compensatory sweating was significant. With most individuals, the increase in sweating was several fold. In some cases the increase was five-fold. For more information, you can consult our compensatory hyperhidrosis webpage.
*Influence of BMI on Compensatory Sweating in Patients after Thoracic Sympathectomy due to Palmar Hyperhidrosis, Thorac Cardiovasc Surg, January, 2017
]]>
<![CDATA[New Focal Hyperhidrosis Forum]]>Fri, 24 Mar 2017 17:36:41 GMThttp://drypharmacist.com/sweating-matters-blog/new-focal-hyperhidrosis-forum
One of the best ways of learning is based on the exchange of ideas and experiences. This is particularly true when the process involves individuals that have common objectives. In this case, learning about focal hyperhidrosis and how best to treat it. That's the reason we decided to introduce the Sweating Matters Forum. For those less familiar with a forum, think of it as a hyperhidrosis discussion room or message board where you can express and post questions, ideas and experiences. Participants are free to come and go, and are welcome to respond to discussion points that are posted in the room.

As the  frequency of visits increases, the forum perpetuates exchanges including invaluable observations, comments or answers to your posted discussion points. One of the more rewarding aspects of such a forum is the opportunity to talk to other individuals that live with an excessive sweating condition. Ultimately, a hyperhidrosis support group is created. We hope many of our website visitors will include stopovers to the Sweating Matters Forum. Look for our Sweating Matters Forum icon below for access to the forum. We will keep the icon on our Home page for easy access to the forum. Welcome to our the Sweating Matters Forum, a focal hyperhidrosis forum. Happy discussions!
]]>